Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India
· Delayed Price · Currency is INR | Market Cap | 3.94T |
| Revenue (ttm) | 516.03B |
| Net Income (ttm) | 114.34B |
| Shares Out | 2.40B |
| EPS (ttm) | 47.71 |
| PE Ratio | 34.45 |
| Forward PE | 33.92 |
| Dividend | 15.50 (0.94%) |
| Ex-Dividend Date | n/a |
| Volume | 2,244,112 |
| Average Volume | 2,417,334 |
| Open | 1,678.05 |
| Previous Close | 1,669.30 |
| Day's Range | 1,632.00 - 1,684.40 |
| 52-Week Range | 1,377.20 - 1,960.35 |
| Beta | 0.59 |
| RSI | 33.47 |
| Earnings Date | Jan 27, 2025 |
About NSE:SUNPHARMA
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and othe... [Read more]
Financial Performance
In 2023, NSE:SUNPHARMA's revenue was 484.97 billion, an increase of 10.51% compared to the previous year's 438.86 billion. Earnings were 95.76 billion, an increase of 13.01%.
Financial StatementsNews
HSBC on pharma stocks: US tariff concerns overdone; Sun Pharma, Torrent Pharma shares to see minimal impact
HSBC has stated that concerns regarding US tariffs on Indian pharmaceutical companies appear overdone, as Indian firms supply 60% of the generic drug volume to the US, playing a key role in cost reduc...
Nifty 50 top gainers today on February 13: Tata Steel, Sun Pharmaceutical, Bajaj Finserv, Bajaj Finance and more
Indian benchmark indices closed on a flat note on February 13, 2024, with the Nifty 50 maintaining its position above the crucial 23,000 mark. The Sensex declined slightly by 32.11 points (0.04%) to s...
Sun Pharma and Philogen announce completion of patient enrollment for Phase III FIBROSARC trial
The trial, conducted across Germany, France, Italy, Spain, and Poland, has exceeded its enrollment target with 129 patients enrolled against the planned 118. Key results from this study are anticipate...
Sun Pharma, Reliance Industries: Top stock recommendations for today
India Business News: Stock Recos by Brokers 040225BofA Securities has maintained its ‘buy’ recommendation on Reliance Industries with a target price of Rs 1,550 (+24%).
Sun Pharma shares in focus: Jefferies, HSBC bullish with up to 30% upside; CLSA cautious
Sun Pharmaceutical Industries shares are in the spotlight following strong Q3FY25 results, with Jefferies and HSBC maintaining bullish views, while CLSA remains cautious. The stock, currently trading ...
Budget 2025: Stocks in focus as Tata Power, Sun Pharma, IRCON, Aadhar Housing await key policy announcements
The Union Budget 2025 is expected to drive significant market movements today, with stocks from various sectors poised to react based on key policy announcements. Companies like Tata Power, Sun Pharma...
Stock market today: IndusInd Bank, ONGC, Sun Pharma, Bandhan Bank, Vishal Mega Mart among top stocks in focus amid Q3 results
The stock market is expected to remain active today as several companies that announced their Q3 results yesterday will be in focus, along with key developments from the Union Budget 2025. IndusInd Ba...
Sun Pharma Q3 FY25 Results: Net profit rises 24.1% YoY to Rs 3,219.6 crore, gross sales increase 10.5%
Sun Pharmaceutical Industries Limited has reported strong financial performance for the third quarter ending December 31, 2024 (Q3 FY25). The company recorded a 24.1% year-on-year (YoY) growth in adju...
Stocks Hitting 52-Week Low Today, January 29: Star Health, Tata Communications, BHEL, KPIT Technologies, Sun Pharma and more
Indian equity markets maintained their positive momentum, with both the Sensex and Nifty closing higher for the second consecutive session. The Sensex rose by 631.55 points (0.83%), closing at 76,532....
Nifty 50 top losers today on January 28: Sun Pharma, Britannia Industries, Hindalco Industries, Grasim Industries and more
Indian equity indices ended a two-day losing streak and closed higher, with the Nifty finishing at 22,957.25 and the Sensex climbing 535.24 points to 75,901.41. Despite this overall market recovery, s...
Sun Pharma’s subsidiary Taro to acquire Antibe Therapeutics
Sun Pharmaceutical Industries Limited, through its subsidiary TARO Pharmaceuticals Inc., has entered into an agreement to acquire 100% of Antibe Therapeutics Inc., a clinical-stage biotechnology compa...
Sensex jumps over 1,400 pts, best day in nearly 2 months
The sensex surged by 1,436 points, nearly reaching 80,000, driven by broad-based buying and short covering. Gains in banking, IT, auto and metal stocks also fuelled the rally amidst low foreign fund a...
Nifty 50 top losers today on January 2: Sun Pharmaceutical and Britannia Industries lead the decline
Indian equity markets experienced a strong rally on January 2, 2025, with the Nifty 50 and Sensex indices posting impressive gains. The broader market saw buying interest across multiple sectors, push...
Pharma sector stocks performance: Ipca Labs gains 1.23%, Biocon up 0.84%, Sun Pharma and Torrent Pharma slip over 1%
Pharma sector stocks displayed a mixed trend as of 10:33 AM. Ipca Labs led the gainers with a 1.23% rise, followed by Biocon at 0.84% and Dr. Reddy’s at 0.65%. On the downside, Sun Pharma (-1.15%), Au...
Healthcare Sector Stock Update: Sun Pharma up 1.05%, Cipla up 1.22%, Zydus Lifesciences up 2%
The healthcare sector displayed a varied performance in today’s trading session, with pharmaceutical giants leading gains while hospital operators experienced mixed trends. Gainers: Sun Pharmaceutical...
Pharma Sector Stocks: Torrent Pharma (+0.25%) rises; Glenmark (-2.29%), Aurobindo (-2.02%) decline
The pharma sector showed mixed trends during the session as of 12:15 AM. Torrent Pharma was the only gainer, rising ₹8.45 to ₹3,336.30 (+0.25%). Sun Pharma dipped ₹4.95 to ₹1,800.50 (-0.27%), and Dr. ...
Motilal Oswal’s healthcare sector picks: Sun Pharma, IPCA, Mankind, Ajanta, and Glenmark
Motilal Oswal Financial Services has highlighted key stock recommendations in the healthcare sector, projecting strong growth potential for 2024. The focus includes prominent pharmaceutical companies ...
HSBC on Indian Pharma Sector: Strong 2025 Outlook for Cipla, Sun Pharma, and Torrent Pharma
HSBC retains a positive view on Indian pharmaceutical companies, projecting strong performance in 2025 led by peak gRevlimid sales and differentiated launches in the US. Companies under HSBC’s coverag...
Brokerage radar: Ceat, Sun Pharma, Godrej Consumer Products, NHPC, Reliance, Tata Power, Lloyd Metals and PG Electroplast in focus today
Brokerage houses have shared their latest insights and price targets for several stocks across industries. Here is a summary of the reports released today, Dec 9, 2024: Ceat Brokerage House: Investec ...
Jefferies on Sun Pharma: Reiterates buy rating with Rs 2150 target, sees 19.23% upside
Jefferies has reaffirmed its ‘Buy’ rating on Sun Pharma, setting a target price of ₹2150, reflecting a potential upside of 19.23% from the current market price of ₹1,803.35. The brokerage analyzed Sun...
Nifty 50 top gainers today on 29 November: Bharti Airtel, Sun Pharmaceutical and Cipla lead the rally
On November 29, 2024, Indian equity indices made a robust comeback, erasing losses from the previous session and closing on a high note. The Nifty 50 surged past the 24,100 mark, while the Sensex rose...
Sun Pharma market cap rises Rs 12,220 crore today
Sun Pharmaceutical Industries witnessed a 2.94% rise in its stock price today, closing at Rs 1,785.20. This surge resulted in an increase of Rs 12,220 crore in the company’s market capitalization, whi...
Pharma stocks: Sun Pharma up 1.27%, Dr. Reddy’s rises 0.82%, Cipla gains 0.53%
The pharmaceutical sector saw broad-based gains in early trade on November 29, 2024, with Cipla and Sun Pharma leading the charge. Here’s a detailed look at the top pharma stocks as of 10:34 AM: Stock...
Nifty 50 top gainers today on 12 November: Trent, Infosys and Sun Pharmaceutical lead the charge
On Tuesday, Indian equity markets closed on a negative note, with the benchmark indices BSE Sensex and NSE Nifty50 both witnessing declines of over 1%. The BSE Sensex ended at 78,675.18, shedding 820....
Sun Pharmaceutical’s market cap falls ₹16,816 crore as shares decline 3.92%
Sun Pharmaceutical Industries Limited experienced a sharp decline in its market capitalization, dropping by approximately ₹16,816 crore as its shares fell 3.92% to ₹1,785.50 on the NSE. This downturn ...